Aquestive Therapeutics Inc. (AQST)
NASDAQ
Aquestive Therapeutics Inc. Long Term Debt 2017–2025
Aquestive Therapeutics Inc. annual long term debt history from 2019 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- Aquestive Therapeutics Inc. long term debt as of December 31, 2025: 45.0M, a 0.00% increase year-over-year.
- Aquestive Therapeutics Inc. long term debt for 2025 were 45.0M, a 0.00% increase from 2024.
- Aquestive Therapeutics Inc. long term debt for 2024 were 45.0M, a 0.00% increase from 2023.
- Aquestive Therapeutics Inc. long term debt for 2023 were 45.0M, a 12.62% decrease from 2020.
- Aquestive Therapeutics Inc. long term debt for 2020 were 51.5M.
Long Term Debt
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Aquestive Therapeutics Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $45 |
| 2024 | $45 |
| 2023 | $45 |
| 2020 | $52 |
| 2019 | $70 |
Aquestive Therapeutics Inc. Long Term Debt — FAQ
Aquestive Therapeutics Inc. (AQST) long term debt over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see AQST's long term debt history?
The chart and table above show Aquestive Therapeutics Inc.'s long term debt by year and by quarter, including the growth rate.